Search

everythinglearnresearchcommunity

for

Search:↓

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

The document explains how male reproductive hormones work and affect the body.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

AMH is a good marker for diagnosing PCOS, but global standards are needed.